T1	Drug 56 66	antibiotic
T2	Condition 72 83	intolerance
T3	Drug 92 103	clindamycin
T4	Drug 108 118	cephalexin
R1	AND Arg1:T2 Arg2:T3	
R2	AND Arg1:T2 Arg2:T4	
T5	Condition 135 166	persistent cutaneous malignancy
T6	Qualifier 174 192	site of the defect
R3	Has_qualifier Arg1:T5 Arg2:T6	
T7	Temporal 193 231	following the reconstructive procedure
T8	Reference_point 203 231	the reconstructive procedure
T9	Procedure 207 231	reconstructive procedure
R4	AND Arg1:T8 Arg2:T9	
R5	multi Arg1:T7 Arg2:T8	
R6	Has_temporal Arg1:T5 Arg2:T7	
*	OR T1 T2 T5
T10	Temporal 19 45	within one week of surgery
T11	Temporal 11 17	recent
T12	Temporal 0 7	current
R7	Subsumes Arg1:T11 Arg2:T10	
*	OR T12 T11
T13	Scope 0 46	current or recent (within one week of surgery)
T14	Scope 56 231	antibiotic use, intolerance to both clindamycin and cephalexin, discovery of a persistent cutaneous malignancy at the site of the defect following the reconstructive procedure
R8	Has_scope Arg1:T14 Arg2:T13	
